Publications en collaboration avec des chercheurs de Hospital Universitario 12 de Octubre (24)

2024

  1. Can anticoagulation be withdrawn in APS patients after aPL negativization?

    Autoimmunity Reviews, Vol. 23, Núm. 1

  2. Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery)

    Journal of the European Academy of Dermatology and Venereology

2023

  1. Development and validation of a model to predict complex Mohs micrographic surgery in clinical practice: REGESMOSH scale

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 8, pp. 1587-1594

  2. Juvenile idiopathic arthritis in the young adult. Methodology, objectives, and initial data from the JUVENSER registry

    Reumatologia Clinica, Vol. 19, Núm. 6, pp. 328-333

  3. Steroids in Lupus: Enemies or Allies

    Journal of Clinical Medicine, Vol. 12, Núm. 11

2022

  1. Complications Associated with Mohs Micrographic Surgery: Data from the Nationwide Prospective Cohort REGESMOHS

    Dermatology, Vol. 238, Núm. 2, pp. 320-328

  2. Incomplete Mohs surgery: a long-term, nationwide prospective cohort to describe recurrence rate and risk factors (REGESMOHS, Spanish Registry of Mohs Surgery)

    Journal of the European Academy of Dermatology and Venereology

  3. Risk of a Second Skin Cancer in a Cohort of Patients With Nonmelanoma Skin Cancer –Basal Cell Carcinoma or Squamous Cell Carcinoma-Treated With Mohs Micrographic Surgery: A National Prospective Cohort Study

    Actas Dermo-Sifiliograficas, Vol. 113, Núm. 5, pp. 451-458

2021

  1. Effects of covid-19 lockdown on tumour burden of melanoma and cutaneous squamous cell carcinoma

    Acta Dermato-Venereologica, Vol. 101, Núm. 8

  2. Mohs micrographic surgery in dermatofibrosarcoma protuberans: Rate and risk factors for recurrence in a prospective cohort study from the Spanish Registry of Mohs Surgery (REGESMOHS) and review of the literature

    Experimental dermatology, Vol. 30, Núm. 5, pp. 717-722

2020

  1. Localized Acral Sclerosing Langerhans Cell Histiocytosis: A New Form of Presentation of Cutaneous Langerhans Cell Histiocytosis

    The American Journal of dermatopathology, Vol. 42, Núm. 5, pp. 356-359

  2. Methotrexate in juvenile idiopathic arthritis. Adverse effects and associated factors

    Anales de Pediatria, Vol. 92, Núm. 3, pp. 124-131

  3. State of the art of Mohs surgery for rare cutaneous tumors in the Spanish Registry of Mohs Surgery (REGESMOHS)

    International Journal of Dermatology, Vol. 59, Núm. 3, pp. 321-325

2019

  1. Adult-onset Still's disease associated with gastric cancer

    Revista Colombiana de Reumatologia, Vol. 26, Núm. 3, pp. 220-222

  2. Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology

    Actas Dermo-Sifiliograficas, Vol. 110, Núm. 6, pp. 448-459

  3. Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology

    Clinical and Translational Oncology, Vol. 21, Núm. 5, pp. 556-571

2018

  1. Lymph Node Dissection in Patients With Melanoma and Sentinel Lymph Node Metastasis: An Updated, Evidence-Based Decision Algorithm

    Actas Dermo-Sifiliograficas, Vol. 109, Núm. 5, pp. 390-398

2017

  1. Rituximab therapy for refractory thrombocytopenia in patients with antiphospholipid antibodies

    Anales de Pediatria, Vol. 87, Núm. 1, pp. 51-53

2016

  1. Osteomielitis crónica no bacteriana: experiencia en un hospital terciario

    Anales de Pediatria, Vol. 85, Núm. 1, pp. 18-25

  2. Subcutaneous immunoglobulin in refractory juvenile dermatomyositis

    Pediatrics, Vol. 137, Núm. 4